We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Administration of 5-FU bolus did not affect survival for ...
Dr. Gabriel A. Brooks discusses the recent FDA product labeling update for Xeloda and 5-FU which aims to highlight risks associated with DPD deficiency. According to an update from the Food and Drug ...
Correlation of postoperative CEA trends with survival and patterns of recurrence after hepatectomy for colorectal cancer metastases. Background: 5-fluorouracil (5-FU) 50 years after its first ...
Dr. Gabriel A. Brooks discusses what DPD deficiency is and why it is important for patients with cancer receiving 5-FU or Xeloda to be aware of it. The Food and Drug Administration (FDA) has updated ...
Three topical dermatologic medications and two classes of topical drugs used in humans are especially hazardous to pets exposed to these drugs, a scoping review found. Cats and dogs died in nearly a ...
New research just published online by JNCCN - Journal of the National Comprehensive Cancer Network finds that for many commonly used treatment regimens targeting metastatic gastrointestinal (GI) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results